Melatonin (Simple English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melatonin" in Simple English language version.

refsWebsite

Global rank Simple English rank

9nih.gov

4^th place

6^th place

8doi.org

2^nd place

3^rd place

4web.archive.org

1^st place

3semanticscholar.org

11^th place

9^th place

1sleepdex.org

low place

1archive.org

6^th place

4^th place

1harvard.edu

18^th place

14^th place

1ahrq.gov

9,469^th place

7,704^th place

1europa.eu

68^th place

38^th place

1tga.gov.au

3,984^th place

7,828^th place

1pharmaceutical-journal.com

low place

2,232^nd place

ahrq.gov

archive.ahrq.gov

Buscemi N.; et al. (2004). "Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment #108 (108). Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services: 1–7. doi:10.1037/e439412005-001. PMC 4781368. PMID 15635761. Archived from the original (PDF) on 3 May 2013. Retrieved 5 June 2013.

archive.org

Paredes S.D.; et al. (2009). "Phytomelatonin: a review". J. Exp. Bot. 60 (1): 57–69. doi:10.1093/jxb/ern284. PMID 19033551.

doi.org

Caniato R.; et al. (2003). "Melatonin in Plants". Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology. Vol. 527. pp. 593–7. doi:10.1007/978-1-4615-0135-0_68. ISBN 978-0-306-47755-3. PMID 15206778.
Paredes S.D.; et al. (2009). "Phytomelatonin: a review". J. Exp. Bot. 60 (1): 57–69. doi:10.1093/jxb/ern284. PMID 19033551.
Altun A. & Ugur-Altun B. (2007). "Melatonin: therapeutic and clinical utilization". Int. J. Clin. Pract. 61 (5): 835–45. doi:10.1111/j.1742-1241.2006.01191.x. PMID 17298593. S2CID 18050554.
Kaur C. & Ling E.A. (2008). "Antioxidants and neuroprotection in the adult and developing central nervous system". Curr. Med. Chem. 15 (29): 3068–80. doi:10.2174/092986708786848640. PMID 19075654.
Boutin J.A.; et al. (2005). "Molecular tools to study melatonin pathways and actions". Trends Pharmacol. Sci. 26 (8): 412–9. doi:10.1016/j.tips.2005.06.006. PMID 15992934.
Hardeland R (2005). "Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance". Endocrine. 27 (2): 119–30. doi:10.1385/ENDO:27:2:119. PMID 16217125. S2CID 46984486.
Reiter R.J.; Acuña-Castroviejo; Tan; Burkhardt; et al. (2001). "Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system". Ann. N.Y. Acad. Sci. 939 (1): 200–15. Bibcode:2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID 11462772. S2CID 20404509.
Buscemi N.; et al. (2004). "Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment #108 (108). Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services: 1–7. doi:10.1037/e439412005-001. PMC 4781368. PMID 15635761. Archived from the original (PDF) on 3 May 2013. Retrieved 5 June 2013.

europa.eu

ema.europa.eu

European Medicines Agency. "Circadin, melatonin". European Public Assessment Report (EPAR). European Medicines Agency. Archived from the original on 21 February 2018. Retrieved 5 June 2013.

harvard.edu

ui.adsabs.harvard.edu

Reiter R.J.; Acuña-Castroviejo; Tan; Burkhardt; et al. (2001). "Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system". Ann. N.Y. Acad. Sci. 939 (1): 200–15. Bibcode:2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID 11462772. S2CID 20404509.

nih.gov

pubmed.ncbi.nlm.nih.gov

Caniato R.; et al. (2003). "Melatonin in Plants". Developments in Tryptophan and Serotonin Metabolism. Advances in Experimental Medicine and Biology. Vol. 527. pp. 593–7. doi:10.1007/978-1-4615-0135-0_68. ISBN 978-0-306-47755-3. PMID 15206778.
Paredes S.D.; et al. (2009). "Phytomelatonin: a review". J. Exp. Bot. 60 (1): 57–69. doi:10.1093/jxb/ern284. PMID 19033551.
Altun A. & Ugur-Altun B. (2007). "Melatonin: therapeutic and clinical utilization". Int. J. Clin. Pract. 61 (5): 835–45. doi:10.1111/j.1742-1241.2006.01191.x. PMID 17298593. S2CID 18050554.
Kaur C. & Ling E.A. (2008). "Antioxidants and neuroprotection in the adult and developing central nervous system". Curr. Med. Chem. 15 (29): 3068–80. doi:10.2174/092986708786848640. PMID 19075654.
Boutin J.A.; et al. (2005). "Molecular tools to study melatonin pathways and actions". Trends Pharmacol. Sci. 26 (8): 412–9. doi:10.1016/j.tips.2005.06.006. PMID 15992934.
Hardeland R (2005). "Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance". Endocrine. 27 (2): 119–30. doi:10.1385/ENDO:27:2:119. PMID 16217125. S2CID 46984486.
Reiter R.J.; Acuña-Castroviejo; Tan; Burkhardt; et al. (2001). "Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system". Ann. N.Y. Acad. Sci. 939 (1): 200–15. Bibcode:2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID 11462772. S2CID 20404509.
Buscemi N.; et al. (2004). "Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment #108 (108). Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services: 1–7. doi:10.1037/e439412005-001. PMC 4781368. PMID 15635761. Archived from the original (PDF) on 3 May 2013. Retrieved 5 June 2013.

ncbi.nlm.nih.gov

Buscemi N.; et al. (2004). "Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment #108 (108). Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services: 1–7. doi:10.1037/e439412005-001. PMC 4781368. PMID 15635761. Archived from the original (PDF) on 3 May 2013. Retrieved 5 June 2013.

pharmaceutical-journal.com

Robinson, Julia. "Number of children prescribed melatonin up 170% in seven years". The Pharmaceutical Journal. Retrieved 2023-02-10.

semanticscholar.org

api.semanticscholar.org

Altun A. & Ugur-Altun B. (2007). "Melatonin: therapeutic and clinical utilization". Int. J. Clin. Pract. 61 (5): 835–45. doi:10.1111/j.1742-1241.2006.01191.x. PMID 17298593. S2CID 18050554.
Hardeland R (2005). "Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance". Endocrine. 27 (2): 119–30. doi:10.1385/ENDO:27:2:119. PMID 16217125. S2CID 46984486.
Reiter R.J.; Acuña-Castroviejo; Tan; Burkhardt; et al. (2001). "Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system". Ann. N.Y. Acad. Sci. 939 (1): 200–15. Bibcode:2001NYASA.939..200R. doi:10.1111/j.1749-6632.2001.tb03627.x. PMID 11462772. S2CID 20404509.

sleepdex.org

"Melatonin". Sleepdex. Archived from the original on 2015-09-24. Retrieved 2011-08-17.

tga.gov.au

Therapeutic Goods Administration (TGA). "Australian Public Assessment Report for Melatonin" (PDF). Department of Health and Ageing, Australian Government. Archived from the original (PDF) on 3 September 2013. Retrieved 5 June 2013.

web.archive.org

"Melatonin". Sleepdex. Archived from the original on 2015-09-24. Retrieved 2011-08-17.
Buscemi N.; et al. (2004). "Melatonin for treatment of sleep disorders" (PDF). Evidence Report/Technology Assessment #108 (108). Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services: 1–7. doi:10.1037/e439412005-001. PMC 4781368. PMID 15635761. Archived from the original (PDF) on 3 May 2013. Retrieved 5 June 2013.
European Medicines Agency. "Circadin, melatonin". European Public Assessment Report (EPAR). European Medicines Agency. Archived from the original on 21 February 2018. Retrieved 5 June 2013.
Therapeutic Goods Administration (TGA). "Australian Public Assessment Report for Melatonin" (PDF). Department of Health and Ageing, Australian Government. Archived from the original (PDF) on 3 September 2013. Retrieved 5 June 2013.